Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2025-11-13 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated November 13, 2025, addressed to stock exchanges regarding the schedule of an upcoming analyst/institutional investor meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an intimation about the schedule of investor meetings, not the meeting materials or a report. The document length is only 1431 characters, indicating it is a brief announcement rather than a detailed report or transcript. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about investor meetings, not an investor presentation or call transcript itself.
2025-11-13 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of newspaper advertisements related to the dispatch of a Postal Ballot Notice to shareholders. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulations 30 and 47, which pertain to disclosure and communication requirements. The content is about announcing the dispatch of a Postal Ballot Notice and includes a request to take the advertisement on record. There is no substantive financial data, management discussion, or detailed report content. The document is essentially an announcement of a regulatory communication (the newspaper advertisement) rather than the report or notice itself. It is not a full Annual Report, Interim Report, or any financial statement. It also does not fit into categories like Board/Management changes, Earnings Release, or Legal Proceedings. Given the nature of the document as a formal regulatory announcement related to shareholder communication, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-11-08 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice from Dr. Lal PathLabs Limited dated November 7, 2025. It references the Companies Act, 2013, SEBI regulations, and details resolutions to be approved by shareholders via postal ballot, including approval of an Employee Restricted Stock Unit Plan, grant of options to employees, increase in authorized share capital, and issuing bonus equity shares. The document is a notice seeking shareholder approval for corporate actions and stock plans, not a report of voting results or a financial report. It is a formal communication to shareholders about proposed resolutions to be voted on remotely. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or ballots. The document is lengthy (15,000 characters) and contains detailed explanatory statements and resolutions, consistent with a PSI filing rather than a simple announcement or voting results declaration.
2025-11-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q2 and H1 FY26 earnings conference call for Dr. Lal PathLabs. It includes management speeches, financial performance highlights, operational updates, and a Q&A session with analysts and investors. The presence of detailed financial data such as revenue, EBITDA, PAT, EPS, and operational metrics confirms it is a comprehensive earnings discussion. The document explicitly states it is a transcript of the earnings conference call, which matches the definition of a Call Transcript (CT). The length of the document (15,000 characters) and the detailed content confirm it is not a brief announcement or a report publication notice. Therefore, the correct classification is Call Transcript (CT).
2025-11-06 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the publication of newspaper advertisements of the company's financial results for the quarter and half year ended September 30, 2025. It references compliance with SEBI regulations and mentions that the financial results have been published in newspapers. The document itself is not the financial results report but an announcement that the advertisement of the financial results has been published. The document length is 15,000 characters, but the content is primarily a notification of publication rather than the report itself. Therefore, according to the MENU VS MEAL rule, this is a Report Publication Announcement (RPA).
2025-11-01 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the announcement of a regulatory event—in this case, receipt of an Assessment Order and Demand Notice from the Income Tax Department. The document includes details of the order but does not contain financial statements or detailed financial analysis. It is a regulatory announcement informing the stock exchanges and public about a material event affecting the company. The document length is short (2821 characters) and it serves as a notification rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-11-01 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.